| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eacc5e001c335b18ba28d2db0f8d95d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bba48fac3096538deab0249465e5d62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 |
| filingDate |
2010-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_402aaef8b5d211d1b8bb2215703e2050
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768b98e8c6c8bab16c79a39cb5b39f5f |
| publicationDate |
2011-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011022315-A1 |
| titleOfInvention |
Pyrazinyl phenyl amide t-type calcium channel antagonists |
| abstract |
The present invention is directed to pyrazinyl phenyl amide compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10899695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11213517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10246426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9932314-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10065929-B2 |
| priorityDate |
2009-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |